{
    "1": {
        "question": "What inverse relationship was observed between macrophages and other immune cells in non-small cell lung cancer tumors?",
        "options": {
            "A": "Anti-inflammatory macrophages decreased as NK cells/T cells decreased.",
            "B": "Anti-inflammatory macrophages increased with increased B cells.",
            "C": "Anti-inflammatory macrophages correlated inversely with T cells and NK cell cytotoxicity.",
            "D": "Pro-inflammatory macrophages correlated inversely with T and NK cell cytotoxicity.",
            "E": "Macrophages showed no relationship with T and NK cells.",
            "F": "I don't know."
        }
    },
    "2": {
        "question": "What were the significant molecular changes noted in tumor-associated macrophages (TAMs) in non-small cell lung cancer?",
        "options": {
            "A": "Shifted towards glucose metabolism",
            "B": "Adopted a foetal-like transcriptional signature promoting iron efflux",
            "C": "Increased expression of NK cell markers",
            "D": "Decreased expression of immune checkpoint inhibitors",
            "E": "Increased their pro-inflammatory activity",
            "F": "I don't know."
        }
    },
    "3": {
        "question": "Which immune cell type showed an increased proportion in tumor tissues compared to background?",
        "options": {
            "A": "Neutrophils",
            "B": "NK cells",
            "C": "B cells",
            "D": "Monocytes",
            "E": "\u03b3\u03b4 T cells",
            "F": "I don't know."
        }
    },
    "4": {
        "question": "What does the presence of CAMLs in tumor samples indicate?",
        "options": {
            "A": "Expansion of T-cell populations",
            "B": "Enhanced tumor angiogenesis",
            "C": "Dual expression of myeloid and epithelial genes",
            "D": "Decreased apoptotic cell clearance",
            "E": "Increased interleukin-6 expression",
            "F": "I don't know."
        }
    },
    "5": {
        "question": "Which ligand-receptor pairing was noted to be more prominent in LUSC compared to LUAD?",
        "options": {
            "A": "PD1-PDL1",
            "B": "CD96-NECTIN1",
            "C": "EGFR-AXL",
            "D": "TREM1-TREM2",
            "E": "LGALS9-CD83",
            "F": "I don't know."
        }
    },
    "6": {
        "question": "How was the spatial distribution of cell types mapped in the study?",
        "options": {
            "A": "Using fluorescence microscopy",
            "B": "Through single-cell RNA sequencing alone",
            "C": "Using spatial transcriptomics with the 10x Genomics Visium platform",
            "D": "Via immunohistochemistry",
            "E": "Using proteomics",
            "F": "I don't know."
        }
    },
    "7": {
        "question": "Which cancer subtype had a higher expression of EGFR receptor interactions in the study?",
        "options": {
            "A": "Squamous cell carcinoma",
            "B": "Small-cell lung cancer",
            "C": "Adenocarcinoma",
            "D": "Large-cell carcinoma",
            "E": "Mesothelioma",
            "F": "I don't know."
        }
    },
    "8": {
        "question": "What correlation was observed between fibroblasts and myeloid cells in the tumor microenvironment?",
        "options": {
            "A": "Positive correlation with AT1 cells",
            "B": "Increased correlation with LECs",
            "C": "Negative correlation with lymphocytes",
            "D": "Positive correlation with VEGF expression",
            "E": "No correlation noted",
            "F": "I don't know."
        }
    },
    "9": {
        "question": "What was the change in monocytes observed in tumors compared to background tissue?",
        "options": {
            "A": "Increase in mature monocytes",
            "B": "Significant reduction in monocytes",
            "C": "Unchanged proportion of monocytes",
            "D": "Increase in inflammatory monocytes",
            "E": "Increase in inhibitory monocytes",
            "F": "I don't know."
        }
    },
    "10": {
        "question": "Which two types of tumors exhibited similar cell-type compositions according to the study?",
        "options": {
            "A": "LUAD and LUSC",
            "B": "LUAD and SCLC",
            "C": "LUSC and SCLC",
            "D": "LUAD and large-cell carcinoma",
            "E": "SCLC and large-cell carcinoma",
            "F": "I don't know."
        }
    },
    "11": {
        "question": "Which gene expression profile was observed to promote cholesterol efflux from TAMs in tumors?",
        "options": {
            "A": "High expression of LDLR",
            "B": "Expression of TREM2 and ABCA1",
            "C": "Expression of PRLR and FOXN1",
            "D": "Downregulation of APOE",
            "E": "Increased expression of SOD2",
            "F": "I don't know."
        }
    },
    "12": {
        "question": "What did the researchers use to confirm the presence of CNAs in CAMLs?",
        "options": {
            "A": "Fluorescence in situ hybridization",
            "B": "PCR",
            "C": "Western blot analysis",
            "D": "Copy number karyotyping of tumors (CopyKAT)",
            "E": "Immunohistochemistry",
            "F": "I don't know."
        }
    },
    "13": {
        "question": "What was a key finding regarding PD1-PDL1 interactions in the study?",
        "options": {
            "A": "Increased interaction in LUAD tumors",
            "B": "Detected in LUSC but not in LUAD",
            "C": "Observed in both tumor types",
            "D": "Not observed in either LUAD or LUSC",
            "E": "Dominated the interaction network",
            "F": "I don't know."
        }
    },
    "14": {
        "question": "What role do STAB1+ macrophages play in the tumor microenvironment?",
        "options": {
            "A": "Promote angiogenesis through VEGF signaling",
            "B": "Enhance iron release, supporting tumor progression",
            "C": "Facilitate apoptosis of tumor cells",
            "D": "Engage in strong interaction with T cells to enhance cytotoxicity",
            "E": "Secrete IL-10 to suppress immune function",
            "F": "I don't know."
        }
    },
    "15": {
        "question": "Which factor was NOT indicated as having a significant impact on the cellular composition of the TME in LUAD and LUSC?",
        "options": {
            "A": "Patient sex",
            "B": "Tumor stage",
            "C": "Tissue sampling location",
            "D": "Cancer subtype",
            "E": "Intercellular interactions",
            "F": "I don't know."
        }
    },
    "16": {
        "question": "Which cell type exhibited reduced cytotoxicity in tumor samples according to Figure 1?",
        "options": {
            "A": "B cells",
            "B": "CD4 T cells",
            "C": "Immature myeloid cells",
            "D": "NK cells",
            "E": "Alveolar macrophages",
            "F": "I don't know."
        }
    },
    "17": {
        "question": "Which of the following exhibited transcriptional similarity with foetal macrophages in NSCLC according to the study?",
        "options": {
            "A": "Natural killer (NK) cells",
            "B": "STAB1+ macrophages",
            "C": "Regulatory T cells",
            "D": "Ciliated epithelial cells",
            "E": "Fibroblasts",
            "F": "I don't know."
        }
    },
    "18": {
        "question": "What was the main observation about B cells in tumor versus background tissue?",
        "options": {
            "A": "Decreased abundance in tumors",
            "B": "Increased abundance in tumors",
            "C": "No significant change between tumor and background",
            "D": "Increase in diversity but not number",
            "E": "Reduced activation in tumors",
            "F": "I don't know."
        }
    },
    "19": {
        "question": "What role do CAMLs potentially play in metastatic processes, as suggested by previous studies?",
        "options": {
            "A": "Prevention of tumor cell migration",
            "B": "Facilitation of circulating tumor cell dissemination",
            "C": "Release of pro-inflammatory cytokines",
            "D": "Sequestration of cancer stem cells",
            "E": "Transformation of epithelial cells",
            "F": "I don't know."
        }
    },
    "20": {
        "question": "What did the study reveal about the spatial co-location of ligand-receptor interactions?",
        "options": {
            "A": "No significant differences between tumor and background",
            "B": "Significant co-localization in tumors",
            "C": "Only found in background tissues",
            "D": "Infrequent in both tumor and background",
            "E": "Predominantly on endothelial cells",
            "F": "I don't know."
        }
    },
    "21": {
        "question": "Which transcriptional shift was observed in TAMs in relation to cholesterol?",
        "options": {
            "A": "Enhanced cholesterol synthesis",
            "B": "Shift towards cholesterol import",
            "C": "Increased cholesterol export",
            "D": "Downregulation of cholesterol transport proteins",
            "E": "No change in cholesterol-related gene expression",
            "F": "I don't know."
        }
    },
    "22": {
        "question": "How were immune cell clusters annotated in the scRNA-seq data?",
        "options": {
            "A": "Via automated machine learning algorithms",
            "B": "Using canonical gene expression markers",
            "C": "Through comparative analysis with mouse models",
            "D": "By visual inspection of histological sections",
            "E": "With fluorescent antibody staining",
            "F": "I don't know."
        }
    },
    "23": {
        "question": "What was a notable transcriptional characteristic of anti-inflammatory macrophages in NSCLC tumors?",
        "options": {
            "A": "Lymphocyte activating",
            "B": "High glycolytic flux",
            "C": "Expression of pro-inflammatory cytokines",
            "D": "Iron efflux coupled with low ferritin expression",
            "E": "Cytotoxic activity enhancement",
            "F": "I don't know."
        }
    },
    "24": {
        "question": "Among NSCLC subtypes, which immune checkpoint inhibitors were co-expressed more in LUAD?",
        "options": {
            "A": "CD80/CD86-CTLA4",
            "B": "PD1-PDL1",
            "C": "NECTIN2-TIGIT",
            "D": "LGALS9-HAVCR2",
            "E": "CD96-NECTIN1",
            "F": "I don't know."
        }
    },
    "25": {
        "question": "What was the key finding regarding the role of cholesterol in tumor growth?",
        "options": {
            "A": "Cholesterol limits tumor growth by altering the cell membrane structure.",
            "B": "High extracellular cholesterol from TAMs supports tumor growth.",
            "C": "Cholesterol inhibits angiogenesis within tumors.",
            "D": "Tumor cells synthesize cholesterol to fuel rapid growth.",
            "E": "No specific role of cholesterol was identified in tumor growth.",
            "F": "I don't know."
        }
    },
    "26": {
        "question": "Which transcription factors have been proposed as potential unconventional therapeutic targets for NSCLC based on the study?",
        "options": {
            "A": "APOE and FABP5",
            "B": "SPP1 and FTH1",
            "C": "LYPD3 and LGALS9",
            "D": "TIGIT and TIM3",
            "E": "ABCA1 and EGFR",
            "F": "I don't know."
        }
    },
    "27": {
        "question": "Which foetal-like transcriptional signature promotes cellular iron efflux in TAMs?",
        "options": {
            "A": "Expression of ferritin light chain genes",
            "B": "Upregulation of ferroportin (SLC40A1)",
            "C": "Increased cytokine release",
            "D": "Deregulation of IGF signaling pathway",
            "E": "Activation of glucose transporters",
            "F": "I don't know."
        }
    },
    "28": {
        "question": "What does the significant abundance of CAMLs in tumor tissues correlate with?",
        "options": {
            "A": "Decreased neutrophil presence",
            "B": "Improved patient prognosis",
            "C": "Response to therapeutic interventions",
            "D": "Likelihood of tumor recurrence",
            "E": "Reduction in T cell activation",
            "F": "I don't know."
        }
    },
    "29": {
        "question": "In tumor samples, AT2 cells showed upregulation of genes involved in which two metabolic processes?",
        "options": {
            "A": "Oxidative phosphorylation and glycolysis",
            "B": "Lactate fermentation and gluconeogenesis",
            "C": "Protein synthesis and urea cycle",
            "D": "Fatty acid oxidation and lactate breakdown",
            "E": "Nucleotide synthesis and amino acid degradation",
            "F": "I don't know."
        }
    },
    "30": {
        "question": "Which genes were noted to be upregulated in LUSC CAMLs?",
        "options": {
            "A": "APOE and ABCA1",
            "B": "SLC40A1 and MERTK",
            "C": "KRT17, KRT5, KRT6A",
            "D": "CXCL12 and VEGF",
            "E": "TNF and IL-10",
            "F": "I don't know."
        }
    },
    "31": {
        "question": "What method was used to validate increased cholesterol levels in tumor tissues?",
        "options": {
            "A": "Western blotting for cholesterol transporters",
            "B": "Mass spectrometry of tumor lysates",
            "C": "BODIPY\u2122 493/503 staining",
            "D": "Mass cytometry",
            "E": "RT-PCR for enzyme expression",
            "F": "I don't know."
        }
    },
    "32": {
        "question": "According to the findings, what might be a potential transcriptional origin of CAMLs in the study?",
        "options": {
            "A": "NK cells undergoing transformation",
            "B": "Direct differentiation from circulating monocytes",
            "C": "Fusion of myeloid and tumor cells",
            "D": "Shedding from primary tumor sites",
            "E": "Erythrocyte conversion",
            "F": "I don't know."
        }
    },
    "33": {
        "question": "What was concluded about tissue-resident neutrophils in relation to immunotherapy discussed in the article?",
        "options": {
            "A": "Linked to improved outcomes in PDL1 therapy",
            "B": "Associated with anti-PDL1 therapy failure",
            "C": "No significant involvement in therapy outcomes",
            "D": "Helped prevent metastasis of tumor cells",
            "E": "Increased presence in tumor sites",
            "F": "I don't know."
        }
    },
    "34": {
        "question": "Which method was employed to differentiate tumor cells from non-malignant cells?",
        "options": {
            "A": "Gene expression profiling",
            "B": "Microscopy imaging",
            "C": "Copy number karyotyping of tumors (CopyKAT)",
            "D": "Proteomic analysis",
            "E": "CRISPR gene editing verification",
            "F": "I don't know."
        }
    },
    "35": {
        "question": "Which factor was identified as potentially responsible for the immunosuppressive phenotype of TAMs?",
        "options": {
            "A": "Lack of T-cells in the microenvironment",
            "B": "Engulfment of tumor cell debris",
            "C": "Continuous exposure to radiation therapy",
            "D": "Mutations in tumor suppressor genes",
            "E": "Administration of anti-inflammatory drugs",
            "F": "I don't know."
        }
    },
    "36": {
        "question": "What did researchers hypothesize regarding the role of STAB1+ macrophages in tumor progression?",
        "options": {
            "A": "Prevent tumor proliferation by phagocytosis of cancer cells",
            "B": "Cause DNA damage in tumor cells",
            "C": "Support tumor progression through sustained iron export",
            "D": "Prevent vascularization of the tumor",
            "E": "Allow adaptive immunity to attack the tumor",
            "F": "I don't know."
        }
    },
    "37": {
        "question": "How did the study confirm the colocalization of CAMLs and AT2 cells?",
        "options": {
            "A": "Using immunofluorescence microscopy",
            "B": "Through scRNA-seq cluster analysis",
            "C": "Spatial transcriptomics and correlation analysis",
            "D": "By electron microscopy",
            "E": "Fluorescent in situ hybridization",
            "F": "I don't know."
        }
    },
    "38": {
        "question": "Which cellular pathway was noted to be upregulated in AT2 cells within tumors?",
        "options": {
            "A": "Wnt signaling pathway",
            "B": "Oxidative phosphorylation",
            "C": "MAPK/ERK pathway",
            "D": "NADPH Oxidase pathway",
            "E": "Jak/STAT signaling",
            "F": "I don't know."
        }
    },
    "39": {
        "question": "Which transcriptional shift was noted in AIM\u0278 within the TME?",
        "options": {
            "A": "Increased IL-1\u03b2 and TNF expression",
            "B": "Reduction of cholesterol synthesis",
            "C": "Promotion of cholesterol and lipid transport and metabolism",
            "D": "Enhanced glycolysis",
            "E": "Increased antigen presentation capability",
            "F": "I don't know."
        }
    },
    "40": {
        "question": "What does the potential co-expression of myeloid and epithelial genes in CAMLs suggest?",
        "options": {
            "A": "Activation of epithelial-to-mesenchymal transition (EMT)",
            "B": "Tumor suppression capability",
            "C": "Immune evasion mechanism",
            "D": "Unique cell population participating in tumor microenvironment interactions",
            "E": "Origin from hematopoietic stem cells",
            "F": "I don't know."
        }
    },
    "41": {
        "question": "Regarding the research findings on macrophages, what significant change supports tumor growth?",
        "options": {
            "A": "Decreased M1 macrophages and increased M2 macrophages",
            "B": "Reduced cholesterol uptake",
            "C": "Enhanced phagocytic activity",
            "D": "Increased cytokine secretion",
            "E": "Downregulation of iron efflux mechanisms",
            "F": "I don't know."
        }
    },
    "42": {
        "question": "What potential benefit could LUAD and LUSC patients derive from the study\u2019s findings?",
        "options": {
            "A": "Better radiation therapy outcomes",
            "B": "Tailored immunotherapy targeting specific ICIs such as TIM3, TIGIT, and CD96",
            "C": "Standard chemotherapy treatments",
            "D": "Genetic therapy targeting EGFR",
            "E": "Reduction in tumor proliferation through glycolysis",
            "F": "I don't know."
        }
    },
    "43": {
        "question": "What was not significantly associated with different clinical features in the tumor environment of LUAD and LUSC?",
        "options": {
            "A": "Frequency of immune cell subsets",
            "B": "Cancer stage",
            "C": "Tissue-sampling location",
            "D": "Metabolic rewiring of tumor cells",
            "E": "Type of intercellular interactions",
            "F": "I don't know."
        }
    },
    "44": {
        "question": "Which of the following genes was indicated to have a high expression in STAB1+ macrophages?",
        "options": {
            "A": "SOD2",
            "B": "LYPD3",
            "C": "AIRE",
            "D": "SLC40A1",
            "E": "CD47",
            "F": "I don't know."
        }
    },
    "45": {
        "question": "What new target in immunotherapy does the study propose for NSCLC based on single-cell technologies?",
        "options": {
            "A": "Pattern recognition receptors on macrophages",
            "B": "Apoptotic pathways in epithelial cells",
            "C": "mo-DC2 cells",
            "D": "Toll-like receptors",
            "E": "P53 upregulation",
            "F": "I don't know."
        }
    },
    "46": {
        "question": "What was one characteristic observed in atypical epithelial cells in tumors compared to backgrounds?",
        "options": {
            "A": "Higher expression of KRT19",
            "B": "Co-expression of myeloid markers",
            "C": "Decrease in size and adhesion",
            "D": "Loss of epithelial junction proteins",
            "E": "Increase in cilia length",
            "F": "I don't know."
        }
    },
    "47": {
        "question": "Which of the discrepancies might arise from scRNA-seq data versus STx data in estimating proportions?",
        "options": {
            "A": "Uneven sample sizes",
            "B": "Changes in chemical composition of samples",
            "C": "Differences in cell digestion sensitivity",
            "D": "Genetic bias during sample selection",
            "E": "Environmental factors affecting RNA integrity",
            "F": "I don't know."
        }
    },
    "48": {
        "question": "What was a key feature of STAB1+ macrophages in relation to the tumor microenvironment?",
        "options": {
            "A": "High oxidative stress",
            "B": "Reduced phagocytic activity",
            "C": "Active cholesterol and iron efflux",
            "D": "Promotion of cell apoptosis",
            "E": "Inhibition of angiogenesis",
            "F": "I don't know."
        }
    },
    "49": {
        "question": "Which methodological tool was employed to integrate and analyze cell-type-specific expression profiles spatially?",
        "options": {
            "A": "Seurat v4.3",
            "B": "CopyKAT",
            "C": "cell2location",
            "D": "SCRAN",
            "E": "Harmony",
            "F": "I don't know."
        }
    },
    "50": {
        "question": "What does the presence of tertiary lymphoid structures typically correlate with in NSCLC?",
        "options": {
            "A": "Shorter survival rates",
            "B": "Poor responses to immunotherapy",
            "C": "Longer relapse-free survival",
            "D": "Increased susceptibility to infection",
            "E": "Higher metastatic potential",
            "F": "I don't know."
        }
    }
}